Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in LLY — ELI LILLY & Co

CIK 1452765 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,115,794
-$1,304,830 QoQ
Shares Held
1,764
-52.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,447
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2024
CallValue
$61,750,018
CallShares
69,700
PutValue
$91,783,384
PutShares
103,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. LLY ranks #2 (16.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LLY
ELI LILLY & Co
This page
1,764 $2,115,794

All Filings in LLY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,115,794 1,764
2026-03-31 $3,420,624 3,719
2025-12-31 $8,754,344 8,146
2025-09-30 $3,490,725 4,575
2025-06-30 $2,538,149 3,256
2025-03-31 $6,901,303 8,356
2024-12-31 $3,195,308 4,139
2024-09-30 $91,783,384 103,600
2024-09-30 $61,750,018 69,700
2024-09-30 $14,670,280 16,559
2024-06-30 $71,343,944 78,800
2024-06-30 $82,751,732 91,400
2024-06-30 $13,280,113 14,668
2024-03-31 $46,755,396 60,100
2024-03-31 $842,530 1,083
2024-03-31 $72,894,852 93,700
2023-12-31 $9,469,535 16,245
2023-12-31 $48,382,360 83,000
2023-12-31 $52,579,384 90,200
2023-09-30 $56,398,650 105,000
2023-09-30 $3,608,976 6,719
2023-09-30 $46,032,041 85,700